Jay M Phd Short is Chief Executive Officer of BioAtla, Inc.. Currently has a direct ownership of 1.86 Million shares of BCAB, which is worth approximately $3.19 Million. The most recent transaction as insider was on Feb 16, 2024, when has been sold 417,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.86M
0% 3M change
33.61% 12M change
Total Value Held $3.19 Million

JAY M PHD SHORT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2024
BUY
Grant, award, or other acquisition
-
417,000 Added 18.34%
1,856,283 Common Stock
Dec 20 2023
BUY
Open market or private purchase
$107,000 $2.14 p/Share
50,000 Added 3.36%
1,439,283 Common Stock
Oct 31 2023
SELL
Payment of exercise price or tax liability
$4,245 $1.47 p/Share
2,888 Reduced 0.21%
1,389,283 Common Stock
Sep 30 2023
SELL
Payment of exercise price or tax liability
$4,909 $1.7 p/Share
2,888 Reduced 0.21%
1,392,171 Common Stock
Aug 31 2023
SELL
Payment of exercise price or tax liability
$7,248 $2.51 p/Share
2,888 Reduced 0.21%
1,395,059 Common Stock
Jul 31 2023
SELL
Payment of exercise price or tax liability
$8,635 $2.99 p/Share
2,888 Reduced 0.21%
1,397,947 Common Stock
Jun 30 2023
SELL
Payment of exercise price or tax liability
$8,664 $3.0 p/Share
2,888 Reduced 0.21%
1,400,835 Common Stock
May 31 2023
SELL
Payment of exercise price or tax liability
$9,097 $3.15 p/Share
2,888 Reduced 0.21%
1,403,723 Common Stock
Apr 30 2023
SELL
Payment of exercise price or tax liability
$9,732 $3.37 p/Share
2,888 Reduced 0.2%
1,406,611 Common Stock
Mar 31 2023
SELL
Payment of exercise price or tax liability
$7,739 $2.68 p/Share
2,888 Reduced 0.2%
1,409,499 Common Stock
Mar 29 2023
BUY
Open market or private purchase
$100,776 $2.47 p/Share
40,800 Added 2.81%
1,412,387 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$8,346 $2.89 p/Share
2,888 Reduced 0.21%
1,371,587 Common Stock
Jan 31 2023
SELL
Payment of exercise price or tax liability
$13,329 $3.79 p/Share
3,517 Reduced 0.26%
1,374,475 Common Stock
Dec 31 2022
SELL
Payment of exercise price or tax liability
$38,502 $8.25 p/Share
4,667 Reduced 0.34%
1,377,992 Common Stock
Nov 30 2022
SELL
Payment of exercise price or tax liability
$51,383 $11.01 p/Share
4,667 Reduced 0.34%
1,382,659 Common Stock
Oct 31 2022
SELL
Payment of exercise price or tax liability
$23,798 $6.89 p/Share
3,454 Reduced 0.25%
1,387,326 Common Stock
Sep 30 2022
SELL
Payment of exercise price or tax liability
$22,238 $7.7 p/Share
2,888 Reduced 0.21%
1,390,780 Common Stock
Aug 31 2022
SELL
Payment of exercise price or tax liability
$25,154 $8.71 p/Share
2,888 Reduced 0.21%
1,393,668 Common Stock
Aug 12 2022
BUY
Open market or private purchase
$206,584 $7.84 p/Share
26,350 Added 1.85%
1,396,556 Common Stock
Jul 31 2022
SELL
Payment of exercise price or tax liability
$9,819 $3.4 p/Share
2,888 Reduced 0.21%
1,370,206 Common Stock
Jun 30 2022
SELL
Payment of exercise price or tax liability
$8,231 $2.85 p/Share
2,888 Reduced 0.21%
1,373,094 Common Stock
Jun 22 2022
BUY
Open market or private purchase
$117,296 $2.91 p/Share
40,308 Added 2.85%
1,375,982 Common Stock
Jun 21 2022
BUY
Open market or private purchase
$81,139 $2.79 p/Share
29,082 Added 2.13%
1,335,674 Common Stock
May 31 2022
SELL
Payment of exercise price or tax liability
$6,960 $2.41 p/Share
2,888 Reduced 0.22%
1,306,592 Common Stock
Apr 30 2022
SELL
Payment of exercise price or tax liability
$10,050 $3.48 p/Share
2,888 Reduced 0.22%
1,304,102 Common Stock
JMP

Jay M Phd Short

Chief Executive Officer
San Diego, CA

Track Institutional and Insider Activities on BCAB

Follow BioAtla, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCAB shares.

Notify only if

Insider Trading

Get notified when an Bio Atla, Inc. insider buys or sells BCAB shares.

Notify only if

News

Receive news related to BioAtla, Inc.

Track Activities on BCAB